APOE*3Leiden. CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome

Author(s):
Hoek, A.M. van den; Hoorn, J.W.A. van der; Maas, A.C.; Hoogen, R.M. van den; Nieuwkoop, A. van; Droog, S.; Offerman, E.H.; Pieterman, E.J.; Havekes, L.M.; Princen, H.M.G.
Published
2014
Publication type
Article / Letter to editor
diabetic dyslipidemiainsulin resistanceNAFLDobesitypharmacological treatment
Date issued
2014-06-30
Language
English
Is part of
Diabetes, Obesity and Metabolism (2014), Vol. 16, no. 6, p. 537-544
hdl
1887/103210
doi
10.1111/dom.12252